425 related articles for article (PubMed ID: 26078839)
1. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer].
Chen JC; Li T; Ning XH; Peng SH; Wang JY; Qi NN; Cai L; Gong K
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1124-7. PubMed ID: 27095782
[TBL] [Abstract][Full Text] [Related]
3. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic benefit of second-look transurethral resection of bladder tumors for newly diagnosed T1 bladder cancer: a single-center experience.
Tseng WH; Liu CL; Huang SK; Liao AC; Kuo JR; Hun SH; Chen CH; Su CC; Wang JC; Lee KH; Shen KH; Li CF
Int Urol Nephrol; 2019 Aug; 51(8):1335-1342. PubMed ID: 31129781
[TBL] [Abstract][Full Text] [Related]
5. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH
PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843
[TBL] [Abstract][Full Text] [Related]
6. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
Süer E; Özcan C; Baltacı S; Gülpınar Ö; Burgu B; Haliloğlu A; Bedük Y
Urol Int; 2013; 91(2):182-6. PubMed ID: 23751593
[TBL] [Abstract][Full Text] [Related]
7. The value of a second transurethral resection for T1 bladder cancer.
Schwaibold HE; Sivalingam S; May F; Hartung R
BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
[TBL] [Abstract][Full Text] [Related]
8. Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
Ayati M; Amini E; Shahrokhi Damavand R; Nowroozi MR; Soleimani M; Ranjbar E; Nowroozi A
Urol J; 2019 May; 16(2):152-156. PubMed ID: 30251745
[TBL] [Abstract][Full Text] [Related]
9. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.
Shoshany O; Mano R; Margel D; Baniel J; Yossepowitch O
Urol Oncol; 2014 Jan; 32(1):40.e17-22. PubMed ID: 23911682
[TBL] [Abstract][Full Text] [Related]
10. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
[TBL] [Abstract][Full Text] [Related]
11. Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.
Lee SE; Jeong IG; Ku JH; Kwak C; Lee E; Jeong JS
Urology; 2004 May; 63(5):873-7; discussion 877. PubMed ID: 15134968
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
13. HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3).
Bongiovanni L; Arena V; Vecchio FM; Racioppi M; Bassi P; Pierconti F
Arch Ital Urol Androl; 2013 Jun; 85(2):73-7. PubMed ID: 23820653
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
[TBL] [Abstract][Full Text] [Related]
15. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
[TBL] [Abstract][Full Text] [Related]
16. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
17. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy.
Dwivedi US; Kumar A; Das SK; Trivedi S; Kumar M; Sunder S; Singh PB
Urol Oncol; 2009; 27(5):514-9. PubMed ID: 18639472
[TBL] [Abstract][Full Text] [Related]
18. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.
Cumberbatch MGK; Foerster B; Catto JWF; Kamat AM; Kassouf W; Jubber I; Shariat SF; Sylvester RJ; Gontero P
Eur Urol; 2018 Jun; 73(6):925-933. PubMed ID: 29523366
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
[TBL] [Abstract][Full Text] [Related]
20. Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer.
Onishi T; Sekito S; Shibahara T; Yabana T
Urol Oncol; 2021 Feb; 39(2):132.e1-132.e6. PubMed ID: 32792215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]